Beacon Pharmaceuticals PLC (DSE:BEACONPHAR)
108.20
-1.50 (-1.37%)
At close: Jul 23, 2026
-7.44% (1Y)
| Market Cap | 24.83B -8.0% |
| Revenue (ttm) | 15.57B +30.2% |
| Net Income | 1.46B +74.1% |
| EPS | 6.31 +74.1% |
| Shares Out | 231.00M |
| PE Ratio | 17.04 |
| Forward PE | n/a |
| Dividend | 2.10 (1.94%) |
| Ex-Dividend Date | Nov 17, 2025 |
| Volume | 194,430 |
| Open | 109.80 |
| Previous Close | 109.70 |
| Day's Range | 107.80 - 110.20 |
| 52-Week Range | 96.00 - 147.50 |
| Beta | -0.38 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Oct 29, 2026 |